clinical trial · NCT06770543
Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)
Primary Hypercholesterolemia or Mixed DyslipidemiaInclisiran
brief summary
This non-interventional study is a mandatory regular Post Marketing Surveillance(rPMS) granted by the Korean health authorities, and is conducted to assess the effectiveness and safety of Leqvio® Pre-filled Syringe(inclisiran sodium) in routine clinical practice for the approved indications (primary hypercholesterolemia or mixed dyslipidemia).
started
Aug 13, 2025
primary completion
Jan 2, 2031
completion
Jan 2, 2031
last updated
Dec 22, 2025
official title
Regulatory Post-Marketing Surveillance (rPMS) Study for Leqvio® Pre-filled Syringe(Inclisiran Sodium)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol